Dexcom (DXCM) EBT Margin Growth (1y) (2011 - 2026)
Dexcom (DXCM) EBT Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | -719.00 |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | 687.00 |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 458.00 |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 88.00 |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | 374.00 |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | 343.00 |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | 84.00 |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -126.00 |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | 165.00 |
| 10 | Zimmer Biomet Holdings | 19.21 Bn | 18.80 Bn | 1.54 Bn | 91.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 343.00 |
| Mar 31, 2026 | 772.00 |
| Dec 31, 2025 | 807.00 |
| Sep 30, 2025 | 1,129.00 |
| Jun 30, 2025 | 214.00 |
| Mar 31, 2025 | 51.00 |
| Dec 31, 2024 | -482.00 |
| Sep 30, 2024 | -681.00 |
| Jun 30, 2024 | 42.00 |
| Mar 31, 2024 | 569.00 |
| Dec 31, 2023 | 746.00 |
| Sep 30, 2023 | 566.00 |
| Jun 30, 2023 | 747.00 |
| Mar 31, 2023 | 296.00 |
| Dec 31, 2022 | 1,542.00 |
| Sep 30, 2022 | 177.00 |
| Jun 30, 2022 | -550.00 |
| Mar 31, 2022 | -244.00 |
| Dec 31, 2021 | -2,619.00 |
| Sep 30, 2021 | 223.00 |